Robert Bazemore makes Hutchmed deal his grand finale as Epizyme CEO; Black Diamond reshuffles the deck with departures of CMO, CSO

Robert Bazemore

→ One minute, Epizyme CEO Robert Bazemore helped engineer a partnership with Hutchmed on developing Tazverik in China. The next minute, he gave his job to someone else.

Bazemore stepped aside as Epizyme’s chief executive the same day the biotech announced the deal,...

Click to view original post